Dunnick J K, Badger R S, Takeda Y, Kriss J P
J Nucl Med. 1976 Dec;17(12):1073-6.
Artificial lipid vesicles (artificial membranes) were shown to bind human 125I-antithyroglobulin (anti-Tg) and human 125I-thyrotropin. Vesicles made with gangliosides bound more antibody and hormone than vesicles lacking them. These gangliosides contained a variety of carbohydrates including glucose, galactose, N-acetyl-galactosamine, and sialic acid. The in vivo stability of antibody-vesicle complexes was a function of vesicle composition: vesicles were most stable when formed from phosphatidylcholine, cholesterol, and gangliosides. Anti-Tg-vesicle complexes bind to thyroglobulin, indicating that at least some of the antibody associated with the vesicle still retains ability to bind to its specific antigen. The addition of a specific antibody or hormone to artificial lipid vesicles may serve as a mechanism to confer specificity to the vesicle in vivo.
人工脂质囊泡(人工膜)已被证明能结合人125I-抗甲状腺球蛋白(抗Tg)和人125I-促甲状腺激素。含有神经节苷脂的囊泡比不含神经节苷脂的囊泡结合更多的抗体和激素。这些神经节苷脂含有多种碳水化合物,包括葡萄糖、半乳糖、N-乙酰半乳糖胺和唾液酸。抗体-囊泡复合物在体内的稳定性是囊泡组成的函数:当由磷脂酰胆碱、胆固醇和神经节苷脂形成囊泡时最稳定。抗Tg-囊泡复合物与甲状腺球蛋白结合,表明与囊泡相关的至少一些抗体仍保留与其特异性抗原结合的能力。向人工脂质囊泡中添加特异性抗体或激素可能是一种在体内赋予囊泡特异性的机制。